Insulet Corp. logo
PODDInsulet Corp.

Quick Ratio (Acid-Test): 1.81

popular:market cap|pe ratio|revenue|price history|total return

Is the quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 1.81 is 41% below its 5-year average of 3.09, near the low end of its 5-year range (1.79–5.45).

As of Thursday, June 25, 2026. 21.04% below its 12-month average of 2.30.

Current Ratio|Debt to Equity|P/FCF Ratio|All Metrics
Quick Ratio

PODD Quick Ratio

1.81

Reported quarterly quick ratio; no daily interpolation.

-62.90% 5Y
PODD Quick Ratio (Acid-Test)

PODD Average Quick Ratio (Acid-Test) Chart

PODD Quick Ratio (Acid-Test)

PODD Current vs Average Quick Ratio (Acid-Test) Chart

PODD Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

1.81

QUICK RATIO (ACID-TEST) AVG TTM

2.30

QUICK RATIO (ACID-TEST) AVG 3Y

2.37

QUICK RATIO (ACID-TEST) AVG 5Y

3.09

QUICK RATIO (ACID-TEST) AVG 10Y

3.97

QUICK RATIO (ACID-TEST) AVG 15Y

3.96

QUICK RATIO (ACID-TEST) AVG 20Y

4.08

CURRENT VS TTM AVG

-21.04%

CURRENT VS 3Y AVG

-23.41%

CURRENT VS 5Y AVG

-41.22%

CURRENT VS 10Y AVG

-54.29%

CURRENT VS 15Y AVG

-54.19%

CURRENT VS 20Y AVG

-55.57%

PODD Competitors' Quick Ratio (Acid-Test)

NAMEMARKET CAPQUICK RATIO (ACID-TEST)TTM3Y5Y
Insulet Corp. (PODD)$10.31B1.812.302.373.09
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B0.370.330.350.35
Baxter International Inc. (BAX)vs ›$10.87B1.561.311.231.40
Charles River Laboratories International, Inc. (CRL)vs ›$9.73B1.021.071.101.11
Henry Schein, Inc. (HSIC)vs ›$9.55B0.760.770.860.88
Revvity, Inc. (RVTY)vs ›$11.78B1.402.212.021.79
Align Technology, Inc. (ALGN)vs ›$12.24B1.241.171.111.16
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.57B4.194.524.423.69
Oscar Health, Inc. (OSCR)vs ›$7.56B0.950.931.041.20
Solventum Corporation (SOLV)vs ›$13.09B0.890.860.930.94

Liquidity Comparison

Quick Ratio

1.81

Excludes inventory

Current Ratio

2.78

Includes inventory

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio = (Current Assets − Inventory) / Current Liabilities

The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Insulet Corp. (PODD)?
The quick ratio (acid-test) for PODD stock is 1.81.
Is Insulet Corp.'s quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.81 is 41% below its 5-year average of 3.09, near the low end of its 5-year range (1.79–5.45).
What is the TTM average quick ratio (acid-test) for Insulet Corp. (PODD)?
The TTM average quick ratio (acid-test) for PODD stock is 2.30.
What is the 3Y average quick ratio (acid-test) for Insulet Corp. (PODD)?
The 3Y average quick ratio (acid-test) for PODD stock is 2.37.
What is the 5Y average quick ratio (acid-test) for Insulet Corp. (PODD)?
The 5Y average quick ratio (acid-test) for PODD stock is 3.09.
What is the 10Y average quick ratio (acid-test) for Insulet Corp. (PODD)?
The 10Y average quick ratio (acid-test) for PODD stock is 3.97.
What is the 15Y average quick ratio (acid-test) for Insulet Corp. (PODD)?
The 15Y average quick ratio (acid-test) for PODD stock is 3.96.
What is the 20Y average quick ratio (acid-test) for Insulet Corp. (PODD)?
The 20Y average quick ratio (acid-test) for PODD stock is 4.08.

PODD Quick Ratio (Acid-Test) History

DATEQUICK RATIO (ACID-TEST)
2026-03-311.81
2025-12-312.11
2025-09-302.18
2025-06-301.79
2025-03-313.59
2024-12-312.73
2024-09-302.76
2024-06-302.68
2024-03-312.71
2023-12-312.58
2023-09-302.31
2023-06-302.34
2023-03-312.42
2022-12-312.61
2022-09-302.95
2022-06-303.49
2022-03-314.45
2021-12-314.43
2021-09-304.53
2021-06-304.89
2021-03-315.45
2020-12-315.21
2020-09-305.85
2020-06-307.23
2020-03-313.34
2019-12-313.05
2019-09-306.13
2019-06-303.83
2019-03-313.64
2018-12-313.31
2018-09-303.92
2018-06-304.92
2018-03-315.08
2017-12-315.85
2017-09-304.42
2017-06-306.35
2017-03-317.69
2016-12-316.00
2016-09-306.07
2016-06-302.84
2016-03-313.17
2015-12-312.74
2015-09-303.05
2015-06-303.42
2015-03-313.91
2014-12-314.40
2014-09-304.12
2014-06-303.13
2014-03-314.39
2013-12-314.45
2013-09-304.02
2013-06-305.65
2013-03-314.32
2012-12-311.97
2012-09-301.99
2012-06-302.30
2012-03-313.46
2011-12-314.28
2011-09-305.04
2011-06-304.96
2011-03-317.22
2010-12-316.91
2010-09-305.89
2010-06-305.70
2010-03-317.56
2009-12-317.28
2009-09-304.97
2009-06-304.17
2009-03-314.29
2008-12-314.22
2008-09-305.66
2008-06-307.19
2008-03-313.20
2007-12-314.79
2007-09-305.66
2007-06-307.26
2007-03-310.56
2006-12-310.93
2006-09-302.92
2006-06-300.00
2006-03-310.00
2005-12-311.95
2005-09-300.00
2005-06-300.00
2005-03-310.00

Related Metrics

Current RatioDebt to EquityP/FCF RatioAll Metrics

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
www.insulet.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy
View full financials